Department of Burns and Plastic Surgery, AIIMS Bhubaneswar, Odisha, India.
Department of General Surgery, AIIMS Bhubaneswar, Odisha, India.
Langenbecks Arch Surg. 2023 Aug 22;408(1):325. doi: 10.1007/s00423-023-03065-2.
This study aimed to compare the efficacy and safety of on-demand bupivacaine infusion via transversus abdominis plane (TAP) catheter in emergency laparotomy patients.
A non-randomised interventional study was conducted on patients undergoing emergency midline laparotomy. The intervention group received an on-demand infusion of 10 ml 0.5% bupivacaine through TAP catheters, whilst the control group received standard analgesic care. The primary outcome was the amount of rescue analgesic consumption. Secondary outcomes included the post-operative, measured by visual analogue scores (VAS), side effects, time to first flatus, post-operative nausea and vomiting, and pulmonary complications.
One-hundred-twenty patients (58 in the TAP-SOS group, 62 in the control group) were included in the final analysis. The TAP-SOS group showed significantly reduced rescue analgesic requirement by 91% (p < 0.001) and lower VAS scores at 3, 6, 12, and 24 h (adjusted p < 0.00). Time to out-of-bed mobilisation was significantly shorter in the TAP-SOS group by 12.47 h (p < 0.001), and post-operative pulmonary complications were lower by 75% (p < 0.05). There were no significant differences in bowel recovery, catheter-related complications, or post-operative morbidity. No incidences of catheter-site infection were reported on follow-up; however, the catheter tip-culture was positive in 3 (5.17%) patients.
On-demand bupivacaine infusion through a TAP catheter effectively reduced post-operative pain and opioid requirements in emergency laparotomy patients without complications. If an epidural is not an option, the TAP-SOS approach can be a helpful adjunct in implementing the ERAS protocol in an emergency since it allows for early ambulation and better pain management.
本研究旨在比较经腹横肌平面(TAP)导管按需输注布比卡因在急诊剖腹手术患者中的疗效和安全性。
对行急诊正中剖腹手术的患者进行非随机干预性研究。干预组通过 TAP 导管接受 10ml0.5%布比卡因的按需输注,而对照组接受标准镇痛护理。主要结局是抢救性镇痛药物的消耗量。次要结局包括术后测量的视觉模拟评分(VAS)、副作用、首次排气时间、术后恶心呕吐和肺部并发症。
120 例患者(TAP-SOS 组 58 例,对照组 62 例)纳入最终分析。TAP-SOS 组的抢救性镇痛需求显著减少 91%(p<0.001),3、6、12 和 24 小时的 VAS 评分也显著降低(调整后 p<0.00)。TAP-SOS 组下床活动时间显著缩短 12.47 小时(p<0.001),术后肺部并发症降低 75%(p<0.05)。两组肠道恢复、导管相关并发症或术后发病率无显著差异。随访时无导管部位感染报告;然而,3 例(5.17%)患者的导管尖端培养阳性。
经 TAP 导管按需输注布比卡因可有效减轻急诊剖腹手术患者的术后疼痛和阿片类药物需求,且无并发症。如果不能使用硬膜外,TAP-SOS 方法可以作为在急诊中实施 ERAS 方案的有益辅助手段,因为它可以实现早期活动和更好的疼痛管理。